Riot Platforms, Inc. — Director's Dealing 2012

Dec 13, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AspenBio Pharma, Inc. (APPY)
CIK: 0001167419
Period of Report: 2012-12-11

Reporting Person: LANDON JOHN H (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-12-11	Stock Option (Right to Buy)	$2.10	A	17806	Acquired	2012-12-11	Common Stock (17806)	Indirect

Footnotes

F1: The option to purchase 17,806 shares of common stock shall become exercisable in full on December 11, 2013.

F2: Upon the grant to Mr. Landon, the options were assigned to a trust for which Mr. Landon serves as the trustee.

F3: By Self as Trustee for the John H. Landon Trust, U/A dated June 4, 1975, as amended.